Recruiting NCT04763538
Quality and Outcome Measurements of Urological Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Standard of care.
- Who it may be relevant to
- Registry conditions: Urologic Diseases. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Switzerland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.
Interventions
- Other Standard of care
Patients are treated according to the standard of care for each individual disease.
Primary outcome measures
- Disease specific primary endpoint [Time frame: 4-5 years]
Eligibility criteria
Inclusion criteria
- All patients treated at the study sites, signed informed consent
Exclusion criteria
- No consent to record medical history
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Switzerland · 2 centers
- Roland Seiler — Biel
- Department of Urology, Hospital Center Biel — Biel
Identifiers
NCT: NCT04763538 · ID 2020-02852